<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1499</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>9366399</PubmedId>
            <Abstract>Transgenic mice expressing chimeric human (alpha1 and alpha2 HLA-A11 domains) and murine (alpha3, transmembrane, and cytoplasmic H-2Kb domains) class I molecules were derived. These mice were used as a model system to study the immunogenicity of human CTL epitopes and also to examine the aspects of Ag processing differences of mice vs man. Immunization of these mice with seven known HLA-A11-restricted CTL epitopes emulsified in IFA resulted in vigorous specific CTL responses. A larger panel of 45 A11-binding peptides was used to examine the relationship between immunogenicity in the HLA-A11/Kb transgenic mice and HLA-A11 binding capacity. Twenty-one of 28 (75%) peptides with high binding affinities (50% inhibitory concentration (IC50), 2-50 nM) and 7 of 13 (54%) intermediate binding peptides (IC50, 50-500 nM range) were immunogenic. In parallel, 19 of these peptides were used for in vitro primary immunizations of PBMC derived from HLA-A11 healthy human donors. It was found that 8 of 8 peptides that were able to elicit CTL in primary human in vitro cultures were also immunogenic in HLA-A11/Kb mice. Finally, HLA-A11/Kb transgenic mice were found to generate an A11/Kb restricted CTL response following immunization with influenza virus A/PR/8/34, suggesting that, at least to some extent, A11 epitopes are generated by transgenic mice as a result of natural in vivo processing and presentation.</Abstract>
            <ArticleYear>1997</ArticleYear>
            <ArticlePages>4753-61</ArticlePages>
            <ArticleTitle>Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Alexander</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Oseroff</LastName>
                    <ForeName>C</ForeName>
                </Author>
                <Author>
                    <LastName>Sidney</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Wentworth</LastName>
                    <ForeName>P</ForeName>
                </Author>
                <Author>
                    <LastName>Keogh</LastName>
                    <ForeName>E</ForeName>
                </Author>
                <Author>
                    <LastName>Hermanson</LastName>
                    <ForeName>G</ForeName>
                </Author>
                <Author>
                    <LastName>Chisari</LastName>
                    <ForeName>F V</ForeName>
                </Author>
                <Author>
                    <LastName>Kubo</LastName>
                    <ForeName>R T</ForeName>
                </Author>
                <Author>
                    <LastName>Grey</LastName>
                    <ForeName>H M</ForeName>
                </Author>
                <Author>
                    <LastName>Sette</LastName>
                    <ForeName>A</ForeName>
                </Author>
            </Authors>
            <Affiliations>Cytel Corporation, San Diego, CA 92121, USA. alexander@cytelcorp.com</Affiliations>
            <ArticleChemicalList>Epitopes, T-Lymphocyte;H-2 Antigens;HLA-A Antigens;HLA-A11 Antigen;Peptides;Recombinant Fusion Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Cytotoxicity, Immunologic(genetics); Epitopes, T-Lymphocyte(genetics; immunology); H-2 Antigens(genetics); HLA-A Antigens(genetics; immunology); HLA-A11 Antigen; Humans; Influenza A virus(immunology); Lymphocyte Activation(genetics); Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic(genetics; immunology); Peptides(immunology; metabolism); Protein Binding(genetics; immunology); Recombinant Fusion Proteins(biosynthesis; genetics; immunology); Species Specificity; T-Lymphocytes, Cytotoxic(immunology); Transgenes(immunology)</ArticleMeshHeadingsList>
            <Comments>ErratumIn(J Immunol 1999 Mar 1;162(5):3104 )</Comments>
            <Journal>
                <Volume>159</Volume>
                <Issue>10</Issue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <Issn>0022-1767</Issn>
                <MedlineTa>J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>HA p148-158</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GVTAACSHAGK</LinearSequence>
                        <StartingPosition>148</StartingPosition>
                        <EndingPosition>158</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03452</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>23163</EpitopeId>
                <ReferenceStartingPosition>148</ReferenceStartingPosition>
                <ReferenceEndingPosition>158</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table IV</LocationOfData>
                        <TCellId>24637</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GVTAACSHAGK</LinearSequence>
                                            <StartingPosition>148</StartingPosition>
                                            <EndingPosition>158</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03452</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>HA p148-158</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GVTAACSHAGK</LinearSequence>
                                            <StartingPosition>148</StartingPosition>
                                            <EndingPosition>158</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03452</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA p148-158</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GVTAACSHAGK</LinearSequence>
                                        <StartingPosition>148</StartingPosition>
                                        <EndingPosition>158</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03452</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>211044</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>50</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with hemagglutinin (HA) peptide p148-158 were tested for their ability to recognize and lyse peptide-pulsed targets.  CTLs from 3 of the 6 immunized mice were capable of peptide-specific lysis.  CTLs from mice immunized with Influenza A A/PR/8/34 did not recognize targets pulsed with hemagglutinin (HA) peptide p148-158 presented in the context of HLA-A11-H-2Kb hybrid.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>24650</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>30.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA p168-177</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LTEKEGSYPK</LinearSequence>
                        <StartingPosition>168</StartingPosition>
                        <EndingPosition>177</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03452</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>39878</EpitopeId>
                <ReferenceStartingPosition>168</ReferenceStartingPosition>
                <ReferenceEndingPosition>177</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table IV</LocationOfData>
                        <TCellId>24638</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LTEKEGSYPK</LinearSequence>
                                            <StartingPosition>168</StartingPosition>
                                            <EndingPosition>177</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03452</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>HA p168-177</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LTEKEGSYPK</LinearSequence>
                                            <StartingPosition>168</StartingPosition>
                                            <EndingPosition>177</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03452</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA p168-177</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LTEKEGSYPK</LinearSequence>
                                        <StartingPosition>168</StartingPosition>
                                        <EndingPosition>177</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03452</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>211044</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>50</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with hemagglutinin (HA) peptide p168-177 were tested for their ability to recognize and lyse peptide-pulsed targets.  CTLs from 3 of the 6 immunized mice were capable of peptide-specific lysis.  CTLs from mice immunized with Influenza A A/PR/8/34 did not recognize targets pulsed with hemagglutinin (HA) peptide p168-177 presented in the context of HLA-A11-H-2Kb hybrid.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>24651</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>121.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA p314-322</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PVTIGECPK</LinearSequence>
                        <StartingPosition>314</StartingPosition>
                        <EndingPosition>322</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03452</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>49979</EpitopeId>
                <ReferenceStartingPosition>314</ReferenceStartingPosition>
                <ReferenceEndingPosition>322</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table IV</LocationOfData>
                        <TCellId>24639</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>PVTIGECPK</LinearSequence>
                                            <StartingPosition>314</StartingPosition>
                                            <EndingPosition>322</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03452</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>HA p314-322</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>PVTIGECPK</LinearSequence>
                                            <StartingPosition>314</StartingPosition>
                                            <EndingPosition>322</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03452</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA p314-322</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PVTIGECPK</LinearSequence>
                                        <StartingPosition>314</StartingPosition>
                                        <EndingPosition>322</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03452</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>211044</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>33.3</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with hemagglutinin (HA) peptide p314-322 were tested for their ability to recognize and lyse peptide-pulsed targets.  CTLs from 2 of the 6 immunized mice were capable of peptide-specific lysis.  CTLs from mice immunized with Influenza A A/PR/8/34 did not recognize targets pulsed with hemagglutinin (HA) peptide p314-322 presented in the context of HLA-A11-H-2Kb hybrid.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>24652</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.6</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA p458-467</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NVKNLYEKVK</LinearSequence>
                        <StartingPosition>458</StartingPosition>
                        <EndingPosition>467</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03452</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>46406</EpitopeId>
                <ReferenceStartingPosition>458</ReferenceStartingPosition>
                <ReferenceEndingPosition>467</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table IV</LocationOfData>
                        <TCellId>1007735</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus (A/Puerto Rico/8/34(H1N1))</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NVKNLYEKVK</LinearSequence>
                                            <StartingPosition>458</StartingPosition>
                                            <EndingPosition>467</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03452</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of  100-300 hemagglutinating units of influenza A virus (A/PR/8/34).  At week 3 post-immunization, splenocytes were isolated.  At week 3 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA p458-467</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NVKNLYEKVK</LinearSequence>
                                        <StartingPosition>458</StartingPosition>
                                        <EndingPosition>467</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03452</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>211044</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>5</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from 5 out of 5 mice immunized with Influenza A A/PR/8/34 were able to recognize targets pulsed with hemagglutinin (HA) peptide p458-467 presented in the context of HLA-A11/H-2Kb hybrid.  This was the only peptide specifically recognized in the context A11 following immunization with whole virus.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table IV</LocationOfData>
                        <TCellId>24636</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NVKNLYEKVK</LinearSequence>
                                            <StartingPosition>458</StartingPosition>
                                            <EndingPosition>467</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03452</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>HA p458-467</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NVKNLYEKVK</LinearSequence>
                                            <StartingPosition>458</StartingPosition>
                                            <EndingPosition>467</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03452</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HA p458-467</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NVKNLYEKVK</LinearSequence>
                                        <StartingPosition>458</StartingPosition>
                                        <EndingPosition>467</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03452</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>211044</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with hemagglutinin (HA) peptide p458-467 were tested for their ability to recognize and lyse peptide-pulsed targets.  CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>24653</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>51.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 p130-138</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SIIPSGPLK</LinearSequence>
                        <StartingPosition>13</StartingPosition>
                        <EndingPosition>21</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03485.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>58567</EpitopeId>
                <ReferenceStartingPosition>130</ReferenceStartingPosition>
                <ReferenceEndingPosition>138</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table IV</LocationOfData>
                        <TCellId>24641</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SIIPSGPLK</LinearSequence>
                                            <StartingPosition>13</StartingPosition>
                                            <EndingPosition>21</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03485.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>M1 p130-138</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SIIPSGPLK</LinearSequence>
                                            <StartingPosition>13</StartingPosition>
                                            <EndingPosition>21</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03485.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>M1 p130-138</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SIIPSGPLK</LinearSequence>
                                        <StartingPosition>13</StartingPosition>
                                        <EndingPosition>21</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03485.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>211044</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with matrix (M1) peptide p130-138 were tested for their ability to recognize and lyse peptide-pulsed targets.  CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.  CTLs from mice immunized with Influenza A A/PR/8/34 did not recognize targets pulsed with matrix (M1) peptide p130-138 presented in the context of HLA-A11-H-2Kb hybrid.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>24657</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>44.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 p470-480</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KTRPILSPLTK</LinearSequence>
                        <StartingPosition>47</StartingPosition>
                        <EndingPosition>57</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03485.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>33844</EpitopeId>
                <ReferenceStartingPosition>470</ReferenceStartingPosition>
                <ReferenceEndingPosition>480</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table IV</LocationOfData>
                        <TCellId>24642</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KTRPILSPLTK</LinearSequence>
                                            <StartingPosition>47</StartingPosition>
                                            <EndingPosition>57</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03485.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>M1 p470-480</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KTRPILSPLTK</LinearSequence>
                                            <StartingPosition>47</StartingPosition>
                                            <EndingPosition>57</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03485.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>M1 p470-480</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KTRPILSPLTK</LinearSequence>
                                        <StartingPosition>47</StartingPosition>
                                        <EndingPosition>57</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03485.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>211044</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with matrix (M1) peptide p470-480 were tested for their ability to recognize and lyse peptide-pulsed targets.  CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.  CTLs from mice immunized with Influenza A A/PR/8/34 did not recognize targets pulsed with matrix (M1) peptide p470-480 presented in the context of HLA-A11-H-2Kb hybrid.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>24658</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>0.7</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 p179-187</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MVLASTTAK</LinearSequence>
                        <StartingPosition>179</StartingPosition>
                        <EndingPosition>187</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03485.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>42959</EpitopeId>
                <ReferenceStartingPosition>179</ReferenceStartingPosition>
                <ReferenceEndingPosition>187</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table IV</LocationOfData>
                        <TCellId>24643</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MVLASTTAK</LinearSequence>
                                            <StartingPosition>179</StartingPosition>
                                            <EndingPosition>187</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03485.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>M1 p179-187</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MVLASTTAK</LinearSequence>
                                            <StartingPosition>179</StartingPosition>
                                            <EndingPosition>187</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03485.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>M1 p179-187</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MVLASTTAK</LinearSequence>
                                        <StartingPosition>179</StartingPosition>
                                        <EndingPosition>187</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03485.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>211044</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>50</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with matrix (M1) peptide p179-187 were tested for their ability to recognize and lyse peptide-pulsed targets.  CTLs from 3 of the 6 immunized mice were capable of peptide-specific lysis.  CTLs from mice immunized with Influenza A A/PR/8/34 did not recognize targets pulsed with matrix (M1) peptide p179-187 presented in the context of HLA-A11-H-2Kb hybrid.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>24659</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>169.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M1 p243-252</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RMGVQMQRFK</LinearSequence>
                        <StartingPosition>243</StartingPosition>
                        <EndingPosition>252</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03485.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>54898</EpitopeId>
                <ReferenceStartingPosition>243</ReferenceStartingPosition>
                <ReferenceEndingPosition>252</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table IV</LocationOfData>
                        <TCellId>24644</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>RMGVQMQRFK</LinearSequence>
                                            <StartingPosition>243</StartingPosition>
                                            <EndingPosition>252</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03485.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>M1 p243-252</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>RMGVQMQRFK</LinearSequence>
                                            <StartingPosition>243</StartingPosition>
                                            <EndingPosition>252</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03485.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>M1 p243-252</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RMGVQMQRFK</LinearSequence>
                                        <StartingPosition>243</StartingPosition>
                                        <EndingPosition>252</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03485.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>211044</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with matrix (M1) peptide p243-252 were tested for their ability to recognize and lyse peptide-pulsed targets.  CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.  CTLs from mice immunized with Influenza A A/PR/8/34 did not recognize targets pulsed with matrix (M1) peptide p243-252 presented in the context of HLA-A11-H-2Kb hybrid.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>24660</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>94.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NP p220-229</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ATEIRASVGK</LinearSequence>
                        <StartingPosition>22</StartingPosition>
                        <EndingPosition>31</EndingPosition>
                        <SourceMolecule>
                            <IedbAccession>SRC124</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>4940</EpitopeId>
                <ReferenceStartingPosition>220</ReferenceStartingPosition>
                <ReferenceEndingPosition>229</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table IV</LocationOfData>
                        <TCellId>24645</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ATEIRASVGK</LinearSequence>
                                            <StartingPosition>22</StartingPosition>
                                            <EndingPosition>31</EndingPosition>
                                            <SourceMolecule>
                                                <IedbAccession>SRC124</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NP p220-229</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ATEIRASVGK</LinearSequence>
                                            <StartingPosition>22</StartingPosition>
                                            <EndingPosition>31</EndingPosition>
                                            <SourceMolecule>
                                                <IedbAccession>SRC124</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NP p220-229</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ATEIRASVGK</LinearSequence>
                                        <StartingPosition>22</StartingPosition>
                                        <EndingPosition>31</EndingPosition>
                                        <SourceMolecule>
                                            <IedbAccession>SRC124</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>211044</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>50</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with nuclear protein (NP) peptide p220-229 were tested for their ability to recognize and lyse peptide-pulsed targets.  CTLs from 3 of the 6 immunized mice were capable of peptide-specific lysis.  CTLs from mice immunized with Influenza A A/PR/8/34 did not recognize targets pulsed with nuclear protein (NP) peptide p220-229 presented in the context of HLA-A11-H-2Kb hybrid.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>24661</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>75.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NP p189-198</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MVMELVRMIK</LinearSequence>
                        <StartingPosition>189</StartingPosition>
                        <EndingPosition>198</EndingPosition>
                        <SourceMolecule>
                            <IedbAccession>SRC124</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>42975</EpitopeId>
                <ReferenceStartingPosition>189</ReferenceStartingPosition>
                <ReferenceEndingPosition>198</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table IV</LocationOfData>
                        <TCellId>24646</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MVMELVRMIK</LinearSequence>
                                            <StartingPosition>189</StartingPosition>
                                            <EndingPosition>198</EndingPosition>
                                            <SourceMolecule>
                                                <IedbAccession>SRC124</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NP p189-198</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MVMELVRMIK</LinearSequence>
                                            <StartingPosition>189</StartingPosition>
                                            <EndingPosition>198</EndingPosition>
                                            <SourceMolecule>
                                                <IedbAccession>SRC124</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NP p189-198</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MVMELVRMIK</LinearSequence>
                                        <StartingPosition>189</StartingPosition>
                                        <EndingPosition>198</EndingPosition>
                                        <SourceMolecule>
                                            <IedbAccession>SRC124</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>211044</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with nuclear protein (NP) peptide p189-198 were tested for their ability to recognize and lyse peptide-pulsed targets.  CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.  CTLs from mice immunized with Influenza A A/PR/8/34 did not recognize targets pulsed with nuclear protein (NP) peptide p189-198 presented in the context of HLA-A11-H-2Kb hybrid.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>24663</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>203</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>193.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NP p349-357</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GTKVVPRGK</LinearSequence>
                        <StartingPosition>349</StartingPosition>
                        <EndingPosition>357</EndingPosition>
                        <SourceMolecule>
                            <IedbAccession>SRC124</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>22735</EpitopeId>
                <ReferenceStartingPosition>349</ReferenceStartingPosition>
                <ReferenceEndingPosition>357</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table IV</LocationOfData>
                        <TCellId>24647</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GTKVVPRGK</LinearSequence>
                                            <StartingPosition>349</StartingPosition>
                                            <EndingPosition>357</EndingPosition>
                                            <SourceMolecule>
                                                <IedbAccession>SRC124</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NP p349-357</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GTKVVPRGK</LinearSequence>
                                            <StartingPosition>349</StartingPosition>
                                            <EndingPosition>357</EndingPosition>
                                            <SourceMolecule>
                                                <IedbAccession>SRC124</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NP p349-357</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GTKVVPRGK</LinearSequence>
                                        <StartingPosition>349</StartingPosition>
                                        <EndingPosition>357</EndingPosition>
                                        <SourceMolecule>
                                            <IedbAccession>SRC124</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>211044</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>50</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with nuclear protein (NP) peptide p349-357 were tested for their ability to recognize and lyse peptide-pulsed targets.  CTLs from 3 of the 6 immunized mice were capable of peptide-specific lysis.  CTLs from mice immunized with Influenza A A/PR/8/34 did not recognize targets pulsed with nuclear protein (NP) peptide p349-357 presented in the context of HLA-A11-H-2Kb hybrid.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table IV</LocationOfData>
                        <MhcBindingId>24664</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>72.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p419-428</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TVQPIVLPEK</LinearSequence>
                        <StartingPosition>839</StartingPosition>
                        <EndingPosition>848</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03366.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>67128</EpitopeId>
                <ReferenceStartingPosition>419</ReferenceStartingPosition>
                <ReferenceEndingPosition>428</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005545</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TVQPIVLPEK</LinearSequence>
                                            <StartingPosition>839</StartingPosition>
                                            <EndingPosition>848</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03366.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p419-428</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TVQPIVLPEK</LinearSequence>
                                            <StartingPosition>839</StartingPosition>
                                            <EndingPosition>848</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03366.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p419-428</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TVQPIVLPEK</LinearSequence>
                                        <StartingPosition>839</StartingPosition>
                                        <EndingPosition>848</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03366.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>9</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>22.2</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HIV pol peptide p419-428 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 2 of the 9 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>24682</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.4</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p1434-1442</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AVFIHNFKR</LinearSequence>
                        <StartingPosition>1326</StartingPosition>
                        <EndingPosition>1334</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P35963.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>5321</EpitopeId>
                <ReferenceStartingPosition>1434</ReferenceStartingPosition>
                <ReferenceEndingPosition>1442</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005809</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AVFIHNFKR</LinearSequence>
                                            <StartingPosition>1326</StartingPosition>
                                            <EndingPosition>1334</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p1434-1442</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AVFIHNFKR</LinearSequence>
                                            <StartingPosition>1326</StartingPosition>
                                            <EndingPosition>1334</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p1434-1442</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AVFIHNFKR</LinearSequence>
                                        <StartingPosition>1326</StartingPosition>
                                        <EndingPosition>1334</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P35963.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>50</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HIV pol peptide p1434-1442 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 3 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>24687</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>3.3</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Env p49-58</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TVYYGVPVWK</LinearSequence>
                        <StartingPosition>36</StartingPosition>
                        <EndingPosition>45</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P04583.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>67245</EpitopeId>
                <ReferenceStartingPosition>49</ReferenceStartingPosition>
                <ReferenceEndingPosition>58</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005810</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TVYYGVPVWK</LinearSequence>
                                            <StartingPosition>36</StartingPosition>
                                            <EndingPosition>45</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04583.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env p49-58</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TVYYGVPVWK</LinearSequence>
                                            <StartingPosition>36</StartingPosition>
                                            <EndingPosition>45</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04583.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Env p49-58</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TVYYGVPVWK</LinearSequence>
                                        <StartingPosition>36</StartingPosition>
                                        <EndingPosition>45</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P04583.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>33</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>28</NumberOfSubjectsResponded>
                            <ResponseFrequency>84.8</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HIV env peptide p49-58 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 28 of the 33 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>24733</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p325-333</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AIFQSSMTK</LinearSequence>
                        <StartingPosition>263</StartingPosition>
                        <EndingPosition>271</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q9YLQ7</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>1913</EpitopeId>
                <ReferenceStartingPosition>325</ReferenceStartingPosition>
                <ReferenceEndingPosition>333</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005811</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AIFQSSMTK</LinearSequence>
                                            <StartingPosition>263</StartingPosition>
                                            <EndingPosition>271</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>Q9YLQ7</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p325-333</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AIFQSSMTK</LinearSequence>
                                            <StartingPosition>263</StartingPosition>
                                            <EndingPosition>271</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>Q9YLQ7</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p325-333</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AIFQSSMTK</LinearSequence>
                                        <StartingPosition>263</StartingPosition>
                                        <EndingPosition>271</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q9YLQ7</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>5</NumberOfSubjectsResponded>
                            <ResponseFrequency>83.3</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HIV pol peptide p325-333 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 5 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>24734</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4.3</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p1434-1443</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AVFIHNFKRK</LinearSequence>
                        <StartingPosition>1326</StartingPosition>
                        <EndingPosition>1335</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P35963.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>5322</EpitopeId>
                <ReferenceStartingPosition>1434</ReferenceStartingPosition>
                <ReferenceEndingPosition>1443</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005808</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AVFIHNFKRK</LinearSequence>
                                            <StartingPosition>1326</StartingPosition>
                                            <EndingPosition>1335</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p1434-1443</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AVFIHNFKRK</LinearSequence>
                                            <StartingPosition>1326</StartingPosition>
                                            <EndingPosition>1335</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p1434-1443</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AVFIHNFKRK</LinearSequence>
                                        <StartingPosition>1326</StartingPosition>
                                        <EndingPosition>1335</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P35963.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTLs from mice immunized with HIV pol peptide p1434-1443 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 0 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>24735</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>7.1</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p919-928</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QMAVFIHNFK</LinearSequence>
                        <StartingPosition>1324</StartingPosition>
                        <EndingPosition>1333</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P35963.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>51599</EpitopeId>
                <ReferenceStartingPosition>919</ReferenceStartingPosition>
                <ReferenceEndingPosition>928</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005699</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>QMAVFIHNFK</LinearSequence>
                                            <StartingPosition>1324</StartingPosition>
                                            <EndingPosition>1333</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p919-928</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>QMAVFIHNFK</LinearSequence>
                                            <StartingPosition>1324</StartingPosition>
                                            <EndingPosition>1333</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p919-928</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QMAVFIHNFK</LinearSequence>
                                        <StartingPosition>1324</StartingPosition>
                                        <EndingPosition>1333</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P35963.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>50</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HIV pol peptide p919-928 were tested for their ability to recognize and lyse peptide-pulsed targets.  CTLs from 3 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005680</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>8.4</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p1225-1235</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KVYLAWVPAHK</LinearSequence>
                        <StartingPosition>1117</StartingPosition>
                        <EndingPosition>1127</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P35963.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>34266</EpitopeId>
                <ReferenceStartingPosition>1225</ReferenceStartingPosition>
                <ReferenceEndingPosition>1235</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005812</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KVYLAWVPAHK</LinearSequence>
                                            <StartingPosition>1117</StartingPosition>
                                            <EndingPosition>1127</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p1225-1235</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KVYLAWVPAHK</LinearSequence>
                                            <StartingPosition>1117</StartingPosition>
                                            <EndingPosition>1127</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p1225-1235</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KVYLAWVPAHK</LinearSequence>
                                        <StartingPosition>1117</StartingPosition>
                                        <EndingPosition>1127</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P35963.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HIV pol peptide p1225-1235 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005683</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>7.6</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p1253-1262</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KVLFLDGIDK</LinearSequence>
                        <StartingPosition>1145</StartingPosition>
                        <EndingPosition>1154</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P35963.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>34096</EpitopeId>
                <ReferenceStartingPosition>1253</ReferenceStartingPosition>
                <ReferenceEndingPosition>1262</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005813</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KVLFLDGIDK</LinearSequence>
                                            <StartingPosition>1145</StartingPosition>
                                            <EndingPosition>1154</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p1253-1262</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KVLFLDGIDK</LinearSequence>
                                            <StartingPosition>1145</StartingPosition>
                                            <EndingPosition>1154</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p1253-1262</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KVLFLDGIDK</LinearSequence>
                                        <StartingPosition>1145</StartingPosition>
                                        <EndingPosition>1154</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P35963.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HIV pol peptide p1253-1262 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005684</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>7.7</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p1075-1083</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IVIWGKTPK</LinearSequence>
                        <StartingPosition>967</StartingPosition>
                        <EndingPosition>975</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P35963.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>29319</EpitopeId>
                <ReferenceStartingPosition>1075</ReferenceStartingPosition>
                <ReferenceEndingPosition>1083</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005814</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IVIWGKTPK</LinearSequence>
                                            <StartingPosition>967</StartingPosition>
                                            <EndingPosition>975</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p1075-1083</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IVIWGKTPK</LinearSequence>
                                            <StartingPosition>967</StartingPosition>
                                            <EndingPosition>975</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p1075-1083</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IVIWGKTPK</LinearSequence>
                                        <StartingPosition>967</StartingPosition>
                                        <EndingPosition>975</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P35963.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTLs from mice immunized with HIV pol peptide p1075-1083 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 0 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005685</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>16.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p438-446</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ASQIYAGIK</LinearSequence>
                        <StartingPosition>854</StartingPosition>
                        <EndingPosition>862</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P35963.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>4699</EpitopeId>
                <ReferenceStartingPosition>438</ReferenceStartingPosition>
                <ReferenceEndingPosition>446</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005816</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ASQIYAGIK</LinearSequence>
                                            <StartingPosition>854</StartingPosition>
                                            <EndingPosition>862</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p438-446</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ASQIYAGIK</LinearSequence>
                                            <StartingPosition>854</StartingPosition>
                                            <EndingPosition>862</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p438-446</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ASQIYAGIK</LinearSequence>
                                        <StartingPosition>854</StartingPosition>
                                        <EndingPosition>862</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P35963.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HIV pol peptide p438-446 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005842</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>18.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p272-280</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GIPHPAGLK</LinearSequence>
                        <StartingPosition>680</StartingPosition>
                        <EndingPosition>688</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P35963.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>20396</EpitopeId>
                <ReferenceStartingPosition>272</ReferenceStartingPosition>
                <ReferenceEndingPosition>280</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005817</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GIPHPAGLK</LinearSequence>
                                            <StartingPosition>680</StartingPosition>
                                            <EndingPosition>688</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p272-280</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GIPHPAGLK</LinearSequence>
                                            <StartingPosition>680</StartingPosition>
                                            <EndingPosition>688</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p272-280</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GIPHPAGLK</LinearSequence>
                                        <StartingPosition>680</StartingPosition>
                                        <EndingPosition>688</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P35963.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTLs from mice immunized with HIV pol peptide p272-280 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 0 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005845</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>35.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p507-517</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QIYQEPFKNLK</LinearSequence>
                        <StartingPosition>927</StartingPosition>
                        <EndingPosition>937</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P35963.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>51159</EpitopeId>
                <ReferenceStartingPosition>507</ReferenceStartingPosition>
                <ReferenceEndingPosition>517</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005818</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>QIYQEPFKNLK</LinearSequence>
                                            <StartingPosition>927</StartingPosition>
                                            <EndingPosition>937</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p507-517</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>QIYQEPFKNLK</LinearSequence>
                                            <StartingPosition>927</StartingPosition>
                                            <EndingPosition>937</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p507-517</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QIYQEPFKNLK</LinearSequence>
                                        <StartingPosition>927</StartingPosition>
                                        <EndingPosition>937</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P35963.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>5</NumberOfSubjectsResponded>
                            <ResponseFrequency>83.3</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HIV pol peptide p507-517 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 5 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005846</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>21.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p1227-1235</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YLAWVPAHK</LinearSequence>
                        <StartingPosition>1119</StartingPosition>
                        <EndingPosition>1127</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P35963.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>74572</EpitopeId>
                <ReferenceStartingPosition>1227</ReferenceStartingPosition>
                <ReferenceEndingPosition>1235</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005819</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>YLAWVPAHK</LinearSequence>
                                            <StartingPosition>1119</StartingPosition>
                                            <EndingPosition>1127</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p1227-1235</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>YLAWVPAHK</LinearSequence>
                                            <StartingPosition>1119</StartingPosition>
                                            <EndingPosition>1127</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P35963.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p1227-1235</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YLAWVPAHK</LinearSequence>
                                        <StartingPosition>1119</StartingPosition>
                                        <EndingPosition>1127</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P35963.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTLs from mice immunized with HIV pol peptide p1227-1235 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 0 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005851</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>106.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p859-868</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MTKILEPFR</LinearSequence>
                        <StartingPosition>269</StartingPosition>
                        <EndingPosition>277</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q9YLQ7</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>42821</EpitopeId>
                <ReferenceStartingPosition>859</ReferenceStartingPosition>
                <ReferenceEndingPosition>868</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005820</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MTKILEPFR</LinearSequence>
                                            <StartingPosition>269</StartingPosition>
                                            <EndingPosition>277</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>Q9YLQ7</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p859-868</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MTKILEPFR</LinearSequence>
                                            <StartingPosition>269</StartingPosition>
                                            <EndingPosition>277</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>Q9YLQ7</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p859-868</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MTKILEPFR</LinearSequence>
                                        <StartingPosition>269</StartingPosition>
                                        <EndingPosition>277</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q9YLQ7</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>8</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTLs from mice immunized with HIV pol peptide p859-868 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 0 of the 8 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005852</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>378.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Env p2184-2194</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VTVYYGVPVWK</LinearSequence>
                        <StartingPosition>35</StartingPosition>
                        <EndingPosition>45</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P04583.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>71569</EpitopeId>
                <ReferenceStartingPosition>2184</ReferenceStartingPosition>
                <ReferenceEndingPosition>2194</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table III</LocationOfData>
                        <TCellId>1005963</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>T cell CD8+</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>VTVYYGVPVWK</LinearSequence>
                                            <StartingPosition>35</StartingPosition>
                                            <EndingPosition>45</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04583.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Enriched CD8+ T cells were cultured for 7 days and then re-stimulated every 3 days thereafter with peptide-pulsed irradiated autologous APCs (PBMCs cultured with S. Aureus, plus rIL-4 prior to introduction of peptide).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Env p2184-2194</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VTVYYGVPVWK</LinearSequence>
                                        <StartingPosition>35</StartingPosition>
                                        <EndingPosition>45</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P04583.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>4</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>75</ResponseFrequency>
                            <AssayComments>To examine the extent of the overlap of CTL repertoire in A11/Kb transgenic mice relative to human expressing the HLA-A11 antigen, peptides previously tested in A11/Kb mice were evaluated for their ability to induce primary CTL response in human PBMCs in vitro.  The HIV env peptide p2184-2194 was capable of inducing specific lysis of EBV-transformed lymphoblastoid targets expressing A11 in 3 of 4 tested individuals.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005821</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>VTVYYGVPVWK</LinearSequence>
                                            <StartingPosition>35</StartingPosition>
                                            <EndingPosition>45</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04583.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env p2184-2194</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>VTVYYGVPVWK</LinearSequence>
                                            <StartingPosition>35</StartingPosition>
                                            <EndingPosition>45</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04583.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Env p2184-2194</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VTVYYGVPVWK</LinearSequence>
                                        <StartingPosition>35</StartingPosition>
                                        <EndingPosition>45</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P04583.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HIV env peptide p2184-2194 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005853</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>11.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Env p370-380</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RAKWNNTLK</LinearSequence>
                        <StartingPosition>335</StartingPosition>
                        <EndingPosition>343</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P04578.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>53136</EpitopeId>
                <ReferenceStartingPosition>370</ReferenceStartingPosition>
                <ReferenceEndingPosition>380</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005822</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>RAKWNNTLK</LinearSequence>
                                            <StartingPosition>335</StartingPosition>
                                            <EndingPosition>343</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04578.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env p370-380</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>RAKWNNTLK</LinearSequence>
                                            <StartingPosition>335</StartingPosition>
                                            <EndingPosition>343</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04578.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Env p370-380</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RAKWNNTLK</LinearSequence>
                                        <StartingPosition>335</StartingPosition>
                                        <EndingPosition>343</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P04578.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTLs from mice immunized with HIV env peptide p370-380 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 0 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005854</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>188.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Nef p84-92</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AVDLSHFLK</LinearSequence>
                        <StartingPosition>84</StartingPosition>
                        <EndingPosition>92</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P04601.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>5295</EpitopeId>
                <ReferenceStartingPosition>84</ReferenceStartingPosition>
                <ReferenceEndingPosition>92</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005823</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AVDLSHFLK</LinearSequence>
                                            <StartingPosition>84</StartingPosition>
                                            <EndingPosition>92</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04601.4</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Nef p84-92</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AVDLSHFLK</LinearSequence>
                                            <StartingPosition>84</StartingPosition>
                                            <EndingPosition>92</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04601.4</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Nef p84-92</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AVDLSHFLK</LinearSequence>
                                        <StartingPosition>84</StartingPosition>
                                        <EndingPosition>92</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P04601.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HIV nef peptide p84-92 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005855</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>5.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Env GP p768-778</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RLRDLLLIVTR</LinearSequence>
                        <StartingPosition>775</StartingPosition>
                        <EndingPosition>785</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P31819.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>54730</EpitopeId>
                <ReferenceStartingPosition>768</ReferenceStartingPosition>
                <ReferenceEndingPosition>778</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005824</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>RLRDLLLIVTR</LinearSequence>
                                            <StartingPosition>775</StartingPosition>
                                            <EndingPosition>785</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P31819.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env GP p768-778</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>RLRDLLLIVTR</LinearSequence>
                                            <StartingPosition>775</StartingPosition>
                                            <EndingPosition>785</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P31819.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Env GP p768-778</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RLRDLLLIVTR</LinearSequence>
                                        <StartingPosition>775</StartingPosition>
                                        <EndingPosition>785</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P31819.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTLs from mice immunized with HIV env GP peptide p768-778 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 0 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005856</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>6667.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p398-406</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GSTHVSWPK</LinearSequence>
                        <StartingPosition>398</StartingPosition>
                        <EndingPosition>406</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12933.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>22540</EpitopeId>
                <ReferenceStartingPosition>398</ReferenceStartingPosition>
                <ReferenceEndingPosition>406</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005825</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GSTHVSWPK</LinearSequence>
                                            <StartingPosition>398</StartingPosition>
                                            <EndingPosition>406</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p398-406</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GSTHVSWPK</LinearSequence>
                                            <StartingPosition>398</StartingPosition>
                                            <EndingPosition>406</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p398-406</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GSTHVSWPK</LinearSequence>
                                        <StartingPosition>398</StartingPosition>
                                        <EndingPosition>406</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12933.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>9</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>66.7</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HBV pol peptide p398-406 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 6 of the 9 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005857</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>3.1</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p110-118</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IMPARFYPK</LinearSequence>
                        <StartingPosition>110</StartingPosition>
                        <EndingPosition>118</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAP79852.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>27530</EpitopeId>
                <ReferenceStartingPosition>110</ReferenceStartingPosition>
                <ReferenceEndingPosition>118</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005868</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IMPARFYPK</LinearSequence>
                                            <StartingPosition>110</StartingPosition>
                                            <EndingPosition>118</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAP79852.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p110-118</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IMPARFYPK</LinearSequence>
                                            <StartingPosition>110</StartingPosition>
                                            <EndingPosition>118</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAP79852.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p110-118</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IMPARFYPK</LinearSequence>
                                        <StartingPosition>110</StartingPosition>
                                        <EndingPosition>118</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAP79852.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTLs from mice immunized with HBV pol peptide p110-118 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 0 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005858</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4.1</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p654-663</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QAFTFSPTYK</LinearSequence>
                        <StartingPosition>665</StartingPosition>
                        <EndingPosition>674</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12933.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>50253</EpitopeId>
                <ReferenceStartingPosition>654</ReferenceStartingPosition>
                <ReferenceEndingPosition>663</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005869</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>QAFTFSPTYK</LinearSequence>
                                            <StartingPosition>665</StartingPosition>
                                            <EndingPosition>674</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p654-663</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>QAFTFSPTYK</LinearSequence>
                                            <StartingPosition>665</StartingPosition>
                                            <EndingPosition>674</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p654-663</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QAFTFSPTYK</LinearSequence>
                                        <StartingPosition>665</StartingPosition>
                                        <EndingPosition>674</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12933.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTLs from mice immunized with HBV pol peptide p654-663 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 0 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005859</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>11.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p149-159</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>HTLWKAGILYK</LinearSequence>
                        <StartingPosition>149</StartingPosition>
                        <EndingPosition>159</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12933.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>24943</EpitopeId>
                <ReferenceStartingPosition>149</ReferenceStartingPosition>
                <ReferenceEndingPosition>159</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005870</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>HTLWKAGILYK</LinearSequence>
                                            <StartingPosition>149</StartingPosition>
                                            <EndingPosition>159</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p149-159</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>HTLWKAGILYK</LinearSequence>
                                            <StartingPosition>149</StartingPosition>
                                            <EndingPosition>159</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p149-159</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HTLWKAGILYK</LinearSequence>
                                        <StartingPosition>149</StartingPosition>
                                        <EndingPosition>159</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12933.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HBV pol peptide p149-159 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005860</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>14.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p377-386</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LVVDFSQFSR</LinearSequence>
                        <StartingPosition>388</StartingPosition>
                        <EndingPosition>397</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12933.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>40624</EpitopeId>
                <ReferenceStartingPosition>377</ReferenceStartingPosition>
                <ReferenceEndingPosition>386</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005871</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LVVDFSQFSR</LinearSequence>
                                            <StartingPosition>388</StartingPosition>
                                            <EndingPosition>397</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p377-386</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LVVDFSQFSR</LinearSequence>
                                            <StartingPosition>388</StartingPosition>
                                            <EndingPosition>397</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p377-386</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LVVDFSQFSR</LinearSequence>
                                        <StartingPosition>388</StartingPosition>
                                        <EndingPosition>397</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12933.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HBV pol peptide p377-386 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005861</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>17.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p150-159</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TLWKAGILYK</LinearSequence>
                        <StartingPosition>150</StartingPosition>
                        <EndingPosition>159</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12933.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>65148</EpitopeId>
                <ReferenceStartingPosition>150</ReferenceStartingPosition>
                <ReferenceEndingPosition>159</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005874</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TLWKAGILYK</LinearSequence>
                                            <StartingPosition>150</StartingPosition>
                                            <EndingPosition>159</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p150-159</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TLWKAGILYK</LinearSequence>
                                            <StartingPosition>150</StartingPosition>
                                            <EndingPosition>159</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p150-159</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TLWKAGILYK</LinearSequence>
                                        <StartingPosition>150</StartingPosition>
                                        <EndingPosition>159</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12933.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTLs from mice immunized with HBV pol peptide p150-159 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 0 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005862</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>17.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p47-55</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NVSIPWTHK</LinearSequence>
                        <StartingPosition>47</StartingPosition>
                        <EndingPosition>55</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12933.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>46480</EpitopeId>
                <ReferenceStartingPosition>47</ReferenceStartingPosition>
                <ReferenceEndingPosition>55</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005878</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NVSIPWTHK</LinearSequence>
                                            <StartingPosition>47</StartingPosition>
                                            <EndingPosition>55</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p47-55</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NVSIPWTHK</LinearSequence>
                                            <StartingPosition>47</StartingPosition>
                                            <EndingPosition>55</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p47-55</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NVSIPWTHK</LinearSequence>
                                        <StartingPosition>47</StartingPosition>
                                        <EndingPosition>55</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12933.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTLs from mice immunized with HBV pol peptide p47-55 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 0 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005863</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>105.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p735-744</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GTDNSVVLSR</LinearSequence>
                        <StartingPosition>735</StartingPosition>
                        <EndingPosition>744</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA10434.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>22628</EpitopeId>
                <ReferenceStartingPosition>735</ReferenceStartingPosition>
                <ReferenceEndingPosition>744</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005880</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GTDNSVVLSR</LinearSequence>
                                            <StartingPosition>735</StartingPosition>
                                            <EndingPosition>744</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>CAA10434.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p735-744</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GTDNSVVLSR</LinearSequence>
                                            <StartingPosition>735</StartingPosition>
                                            <EndingPosition>744</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>CAA10434.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p735-744</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GTDNSVVLSR</LinearSequence>
                                        <StartingPosition>735</StartingPosition>
                                        <EndingPosition>744</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA10434.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>9</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>33.3</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HBV pol peptide p735-744 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 3 of the 9 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005864</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>107.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p415-424</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LSLDVSAAFY</LinearSequence>
                        <StartingPosition>426</StartingPosition>
                        <EndingPosition>435</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12933.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>39474</EpitopeId>
                <ReferenceStartingPosition>415</ReferenceStartingPosition>
                <ReferenceEndingPosition>424</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005882</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LSLDVSAAFY</LinearSequence>
                                            <StartingPosition>426</StartingPosition>
                                            <EndingPosition>435</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p415-424</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LSLDVSAAFY</LinearSequence>
                                            <StartingPosition>426</StartingPosition>
                                            <EndingPosition>435</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p415-424</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LSLDVSAAFY</LinearSequence>
                                        <StartingPosition>426</StartingPosition>
                                        <EndingPosition>435</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12933.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTLs from mice immunized with HBV pol peptide p415-424 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 0 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005865</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>545.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol p149-158</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>HTLWKAGILY</LinearSequence>
                        <StartingPosition>149</StartingPosition>
                        <EndingPosition>158</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12933.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>24942</EpitopeId>
                <ReferenceStartingPosition>149</ReferenceStartingPosition>
                <ReferenceEndingPosition>158</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005885</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>HTLWKAGILY</LinearSequence>
                                            <StartingPosition>149</StartingPosition>
                                            <EndingPosition>158</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pol p149-158</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>HTLWKAGILY</LinearSequence>
                                            <StartingPosition>149</StartingPosition>
                                            <EndingPosition>158</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pol p149-158</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HTLWKAGILY</LinearSequence>
                                        <StartingPosition>149</StartingPosition>
                                        <EndingPosition>158</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12933.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTLs from mice immunized with HBV pol peptide p149-158 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 0 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005866</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>7500.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ADR X p1523-1531</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TTDLEAYFK</LinearSequence>
                        <StartingPosition>105</StartingPosition>
                        <EndingPosition>113</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12936.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>66568</EpitopeId>
                <ReferenceStartingPosition>1523</ReferenceStartingPosition>
                <ReferenceEndingPosition>1531</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005886</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TTDLEAYFK</LinearSequence>
                                            <StartingPosition>105</StartingPosition>
                                            <EndingPosition>113</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12936.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ADR X p1523-1531</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>Epithelial cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TTDLEAYFK</LinearSequence>
                                            <StartingPosition>105</StartingPosition>
                                            <EndingPosition>113</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12936.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>ADR X p1523-1531</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TTDLEAYFK</LinearSequence>
                                        <StartingPosition>105</StartingPosition>
                                        <EndingPosition>113</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12936.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTLs from mice immunized with HBV ADR X peptide p1523-1531 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 0 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005867</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6.5</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Core p141-151</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>STLPETTVVRR</LinearSequence>
                        <StartingPosition>153</StartingPosition>
                        <EndingPosition>163</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P29178.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>61745</EpitopeId>
                <ReferenceStartingPosition>141</ReferenceStartingPosition>
                <ReferenceEndingPosition>151</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table III</LocationOfData>
                        <TCellId>1005956</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>T cell CD8+</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>STLPETTVVRR</LinearSequence>
                                            <StartingPosition>153</StartingPosition>
                                            <EndingPosition>163</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P29178.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Enriched CD8+ T cells were cultured for 7 days and then re-stimulated every 3 days thereafter with peptide-pulsed irradiated autologous APCs (PBMCs cultured with S. Aureus, plus rIL-4 prior to introduction of peptide).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Core p141-151</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>STLPETTVVRR</LinearSequence>
                                        <StartingPosition>153</StartingPosition>
                                        <EndingPosition>163</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P29178.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>4</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>75</ResponseFrequency>
                            <AssayComments>To examine the extent of the overlap of CTL repertoire in A11/Kb transgenic mice relative to human expressing the HLA-A11 antigen, peptides previously tested in A11/Kb mice were evaluated for their ability to induce primary CTL response in human PBMCs in vitro.  The HBV core peptide p141-151 was capable of inducing specific lysis of EBV-transformed lymphoblastoid targets expressing A11 in 3 of 4 tested individuals.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005890</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>STLPETTVVRR</LinearSequence>
                                            <StartingPosition>153</StartingPosition>
                                            <EndingPosition>163</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P29178.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Core p141-151</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>STLPETTVVRR</LinearSequence>
                                            <StartingPosition>153</StartingPosition>
                                            <EndingPosition>163</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P29178.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Core p141-151</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>STLPETTVVRR</LinearSequence>
                                        <StartingPosition>153</StartingPosition>
                                        <EndingPosition>163</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P29178.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HBV core peptide p141-151 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005891</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NS4 p1863-1872</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GVAGALVAFK</LinearSequence>
                        <StartingPosition>1858</StartingPosition>
                        <EndingPosition>1867</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P29846.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11103</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>22910</EpitopeId>
                <ReferenceStartingPosition>1863</ReferenceStartingPosition>
                <ReferenceEndingPosition>1872</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005893</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GVAGALVAFK</LinearSequence>
                                            <StartingPosition>1858</StartingPosition>
                                            <EndingPosition>1867</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P29846.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11103</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NS4 p1863-1872</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GVAGALVAFK</LinearSequence>
                                            <StartingPosition>1858</StartingPosition>
                                            <EndingPosition>1867</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P29846.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11103</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NS4 p1863-1872</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GVAGALVAFK</LinearSequence>
                                        <StartingPosition>1858</StartingPosition>
                                        <EndingPosition>1867</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P29846.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11103</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HCV ns4 peptide p1863-1872 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table III</LocationOfData>
                        <TCellId>1005959</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>T cell CD8+</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GVAGALVAFK</LinearSequence>
                                            <StartingPosition>1858</StartingPosition>
                                            <EndingPosition>1867</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P29846.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11103</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Enriched CD8+ T cells were cultured for 7 days and then re-stimulated every 3 days thereafter with peptide-pulsed irradiated autologous APCs (PBMCs cultured with S. Aureus, plus rIL-4 prior to introduction of peptide).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NS4 p1863-1872</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GVAGALVAFK</LinearSequence>
                                        <StartingPosition>1858</StartingPosition>
                                        <EndingPosition>1867</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P29846.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11103</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>5</NumberOfSubjectsResponded>
                            <ResponseFrequency>83.3</ResponseFrequency>
                            <AssayComments>To examine the extent of the overlap of CTL repertoire in A11/Kb transgenic mice relative to human expressing the HLA-A11 antigen, peptides previously tested in A11/Kb mice were evaluated for their ability to induce primary CTL response in human PBMCs in vitro.  The HCV ns4 peptide p1863-1867 was capable of inducing specific lysis of EBV-transformed lymphoblastoid targets expressing A11 in 5 of 6 tested individuals.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005892</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4.2</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>MAGE 2 p73-81</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TTINYTLWR</LinearSequence>
                        <StartingPosition>73</StartingPosition>
                        <EndingPosition>81</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P43356.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>66656</EpitopeId>
                <ReferenceStartingPosition>73</ReferenceStartingPosition>
                <ReferenceEndingPosition>81</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005919</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TTINYTLWR</LinearSequence>
                                            <StartingPosition>73</StartingPosition>
                                            <EndingPosition>81</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P43356.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>MAGE 2 p73-81</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TTINYTLWR</LinearSequence>
                                            <StartingPosition>73</StartingPosition>
                                            <EndingPosition>81</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P43356.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>MAGE 2 p73-81</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TTINYTLWR</LinearSequence>
                                        <StartingPosition>73</StartingPosition>
                                        <EndingPosition>81</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P43356.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with human MAGE 2 peptide p73-81 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table III</LocationOfData>
                        <TCellId>1005960</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>T cell CD8+</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TTINYTLWR</LinearSequence>
                                            <StartingPosition>73</StartingPosition>
                                            <EndingPosition>81</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P43356.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Enriched CD8+ T cells were cultured for 7 days and then re-stimulated every 3 days thereafter with peptide-pulsed irradiated autologous APCs (PBMCs cultured with S. Aureus, plus rIL-4 prior to introduction of peptide).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>MAGE 2 p73-81</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TTINYTLWR</LinearSequence>
                                        <StartingPosition>73</StartingPosition>
                                        <EndingPosition>81</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P43356.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>4</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>75</ResponseFrequency>
                            <AssayComments>To examine the extent of the overlap of CTL repertoire in A11/Kb transgenic mice relative to human expressing the HLA-A11 antigen, peptides previously tested in A11/Kb mice were evaluated for their ability to induce primary CTL response in human PBMCs in vitro.  The human MAGE 2 peptide p73-81 was capable of inducing specific lysis of EBV-transformed lymphoblastoid targets expressing A11 in 3 of 4 tested individuals.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005918</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>5.5</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>LSA 1 P1855-1863</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LSTNLPYGK</LinearSequence>
                        <StartingPosition>122</StartingPosition>
                        <EndingPosition>130</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA29775.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>39711</EpitopeId>
                <ReferenceStartingPosition>1855</ReferenceStartingPosition>
                <ReferenceEndingPosition>1863</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005920</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LSTNLPYGK</LinearSequence>
                                            <StartingPosition>122</StartingPosition>
                                            <EndingPosition>130</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29775.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>LSA 1 P1855-1863</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LSTNLPYGK</LinearSequence>
                                            <StartingPosition>122</StartingPosition>
                                            <EndingPosition>130</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29775.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>LSA 1 P1855-1863</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LSTNLPYGK</LinearSequence>
                                        <StartingPosition>122</StartingPosition>
                                        <EndingPosition>130</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA29775.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with P. falciparum LSA 1 peptide p1855-1863 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005921</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>8.6</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>SSP2 p122-130</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LSTNLPYGK</LinearSequence>
                        <StartingPosition>122</StartingPosition>
                        <EndingPosition>130</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA29775.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>39711</EpitopeId>
                <ReferenceStartingPosition>122</ReferenceStartingPosition>
                <ReferenceEndingPosition>130</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005923</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LSTNLPYGK</LinearSequence>
                                            <StartingPosition>122</StartingPosition>
                                            <EndingPosition>130</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29775.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>SSP2 p122-130</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LSTNLPYGK</LinearSequence>
                                            <StartingPosition>122</StartingPosition>
                                            <EndingPosition>130</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29775.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>SSP2 p122-130</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LSTNLPYGK</LinearSequence>
                                        <StartingPosition>122</StartingPosition>
                                        <EndingPosition>130</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA29775.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>33.3</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with P. falciparum SSP2 peptide p122-130 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 2 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005922</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>70.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>trap p511-519</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LACAGLAYK</LinearSequence>
                        <StartingPosition>508</StartingPosition>
                        <EndingPosition>516</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>34701</EpitopeId>
                <ReferenceStartingPosition>511</ReferenceStartingPosition>
                <ReferenceEndingPosition>519</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005924</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LACAGLAYK</LinearSequence>
                                            <StartingPosition>508</StartingPosition>
                                            <EndingPosition>516</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P16893.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>trap p511-519</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LACAGLAYK</LinearSequence>
                                            <StartingPosition>508</StartingPosition>
                                            <EndingPosition>516</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P16893.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>trap p511-519</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LACAGLAYK</LinearSequence>
                                        <StartingPosition>508</StartingPosition>
                                        <EndingPosition>516</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16893.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with P. falciparum  TRAP peptide p511-519 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005925</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>207.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>MAGE 1 p95-104</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ESLFRAVITK</LinearSequence>
                        <StartingPosition>95</StartingPosition>
                        <EndingPosition>104</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P43355.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>14195</EpitopeId>
                <ReferenceStartingPosition>95</ReferenceStartingPosition>
                <ReferenceEndingPosition>104</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005927</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ESLFRAVITK</LinearSequence>
                                            <StartingPosition>95</StartingPosition>
                                            <EndingPosition>104</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P43355.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>MAGE 1 p95-104</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ESLFRAVITK</LinearSequence>
                                            <StartingPosition>95</StartingPosition>
                                            <EndingPosition>104</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P43355.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Other / Unknown</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>MAGE 1 p95-104</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ESLFRAVITK</LinearSequence>
                                        <StartingPosition>95</StartingPosition>
                                        <EndingPosition>104</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P43355.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with human MAGE 1 peptide p95-104 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table III</LocationOfData>
                        <TCellId>1005961</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>T cell CD8+</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ESLFRAVITK</LinearSequence>
                                            <StartingPosition>95</StartingPosition>
                                            <EndingPosition>104</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P43355.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Enriched CD8+ T cells were cultured for 7 days and then re-stimulated every 3 days thereafter with peptide-pulsed irradiated autologous APCs (PBMCs cultured with S. Aureus, plus rIL-4 prior to introduction of peptide).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>MAGE 1 p95-104</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ESLFRAVITK</LinearSequence>
                                        <StartingPosition>95</StartingPosition>
                                        <EndingPosition>104</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P43355.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>To examine the extent of the overlap of CTL repertoire in A11/Kb transgenic mice relative to human expressing the HLA-A11 antigen, peptides previously tested in A11/Kb mice were evaluated for their ability to induce primary CTL response in human PBMCs in vitro.  The human MAGE 1 peptide p95-104 was capable of inducing specific lysis of EBV-transformed lymphoblastoid targets expressing A11 in 2 of 2 tested individuals.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005926</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>1154.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>EBNA p416-424</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IVTDFSVIK</LinearSequence>
                        <StartingPosition>416</StartingPosition>
                        <EndingPosition>424</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03203.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10376</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>29466</EpitopeId>
                <ReferenceStartingPosition>416</ReferenceStartingPosition>
                <ReferenceEndingPosition>424</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005928</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IVTDFSVIK</LinearSequence>
                                            <StartingPosition>416</StartingPosition>
                                            <EndingPosition>424</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03203.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10376</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>EBNA p416-424</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IVTDFSVIK</LinearSequence>
                                            <StartingPosition>416</StartingPosition>
                                            <EndingPosition>424</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03203.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10376</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>EBNA p416-424</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IVTDFSVIK</LinearSequence>
                                        <StartingPosition>416</StartingPosition>
                                        <EndingPosition>424</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03203.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10376</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>5</NumberOfSubjectsResponded>
                            <ResponseFrequency>83.3</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with herpesvirus 4 EBNA peptide p416-424 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 5 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005929</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>18.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>EBNA 4A p399-408</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AVFDRKSDAK</LinearSequence>
                        <StartingPosition>399</StartingPosition>
                        <EndingPosition>408</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03203.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10376</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>5316</EpitopeId>
                <ReferenceStartingPosition>399</ReferenceStartingPosition>
                <ReferenceEndingPosition>408</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005931</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AVFDRKSDAK</LinearSequence>
                                            <StartingPosition>399</StartingPosition>
                                            <EndingPosition>408</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03203.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10376</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>EBNA 4A p399-408</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AVFDRKSDAK</LinearSequence>
                                            <StartingPosition>399</StartingPosition>
                                            <EndingPosition>408</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03203.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10376</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>EBNA 4A p399-408</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AVFDRKSDAK</LinearSequence>
                                        <StartingPosition>399</StartingPosition>
                                        <EndingPosition>408</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03203.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10376</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with herpesvirus 4 EBNA 4A peptide p399-408 were tested for their ability to recognize and lyse peptide-pulsed targets.  CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005930</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>22.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>E7 p88-97</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GIVCPICSQK</LinearSequence>
                        <StartingPosition>88</StartingPosition>
                        <EndingPosition>97</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03129.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>333760</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>20471</EpitopeId>
                <ReferenceStartingPosition>88</ReferenceStartingPosition>
                <ReferenceEndingPosition>97</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table III</LocationOfData>
                        <TCellId>1005962</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>T cell CD8+</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GIVCPICSQK</LinearSequence>
                                            <StartingPosition>88</StartingPosition>
                                            <EndingPosition>97</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03129.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>333760</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Enriched CD8+ T cells were cultured for 7 days and then re-stimulated every 3 days thereafter with peptide-pulsed irradiated autologous APCs (PBMCs cultured with S. Aureus, plus rIL-4 prior to introduction of peptide).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>E7 p88-97</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GIVCPICSQK</LinearSequence>
                                        <StartingPosition>88</StartingPosition>
                                        <EndingPosition>97</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03129.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>333760</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>4</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>50</ResponseFrequency>
                            <AssayComments>To examine the extent of the overlap of CTL repertoire in A11/Kb transgenic mice relative to human expressing the HLA-A11 antigen, peptides previously tested in A11/Kb mice were evaluated for their ability to induce primary CTL response in human PBMCs in vitro.  The HPV 16 E7 peptide p88-97 was capable of inducing specific lysis of EBV-transformed lymphoblastoid targets expressing A11 in 2 of 4 tested individuals.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005933</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GIVCPICSQK</LinearSequence>
                                            <StartingPosition>88</StartingPosition>
                                            <EndingPosition>97</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03129.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>333760</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>E7 p88-97</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GIVCPICSQK</LinearSequence>
                                            <StartingPosition>88</StartingPosition>
                                            <EndingPosition>97</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03129.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>333760</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>E7 p88-97</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GIVCPICSQK</LinearSequence>
                                        <StartingPosition>88</StartingPosition>
                                        <EndingPosition>97</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03129.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>333760</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>9</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>33.3</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with human papillomavirus 16 E7 peptide p88-97 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 3 of the 9 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005934</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>90.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>E6 p106-113</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LLIRCINCQK</LinearSequence>
                        <StartingPosition>106</StartingPosition>
                        <EndingPosition>115</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03126.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>333760</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>37421</EpitopeId>
                <ReferenceStartingPosition>106</ReferenceStartingPosition>
                <ReferenceEndingPosition>113</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005937</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LLIRCINCQK</LinearSequence>
                                            <StartingPosition>106</StartingPosition>
                                            <EndingPosition>115</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03126.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>333760</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>E6 p106-113</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LLIRCINCQK</LinearSequence>
                                            <StartingPosition>106</StartingPosition>
                                            <EndingPosition>115</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03126.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>333760</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>E6 p106-113</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LLIRCINCQK</LinearSequence>
                                        <StartingPosition>106</StartingPosition>
                                        <EndingPosition>115</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03126.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>333760</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with human papillomavirus 16 E6 peptide p106-113 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table III</LocationOfData>
                        <TCellId>1005957</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>T cell CD8+</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LLIRCINCQK</LinearSequence>
                                            <StartingPosition>106</StartingPosition>
                                            <EndingPosition>115</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03126.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>333760</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Enriched CD8+ T cells were cultured for 7 days and then re-stimulated every 3 days thereafter with peptide-pulsed irradiated autologous APCs (PBMCs cultured with S. Aureus, plus rIL-4 prior to introduction of peptide).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>E6 p106-113</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LLIRCINCQK</LinearSequence>
                                        <StartingPosition>106</StartingPosition>
                                        <EndingPosition>115</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03126.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>333760</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>4</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>50</ResponseFrequency>
                            <AssayComments>To examine the extent of the overlap of CTL repertoire in A11/Kb transgenic mice relative to human expressing the HLA-A11 antigen, peptides previously tested in A11/Kb mice were evaluated for their ability to induce primary CTL response in human PBMCs in vitro.  The HPV 16 E6 peptide p106-113 was capable of inducing specific lysis of EBV-transformed lymphoblastoid targets expressing A11 in 2 of 4 tested individuals.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005936</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>33.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ADR Pol p711-719</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AVNHYFKTR</LinearSequence>
                        <StartingPosition>137</StartingPosition>
                        <EndingPosition>145</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12933.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>5485</EpitopeId>
                <ReferenceStartingPosition>711</ReferenceStartingPosition>
                <ReferenceEndingPosition>719</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005939</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AVNHYFKTR</LinearSequence>
                                            <StartingPosition>137</StartingPosition>
                                            <EndingPosition>145</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ADR Pol p711-719</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>T cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AVNHYFKTR</LinearSequence>
                                            <StartingPosition>137</StartingPosition>
                                            <EndingPosition>145</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>ADR Pol p711-719</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AVNHYFKTR</LinearSequence>
                                        <StartingPosition>137</StartingPosition>
                                        <EndingPosition>145</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12933.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>9</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>66.7</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HBV ADR pol peptide p711-719 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 6 of the 9 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005940</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>61.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ADR X p1548-1556</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KVFVLGGCR</LinearSequence>
                        <StartingPosition>130</StartingPosition>
                        <EndingPosition>138</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12936.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>34020</EpitopeId>
                <ReferenceStartingPosition>1548</ReferenceStartingPosition>
                <ReferenceEndingPosition>1556</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005942</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KVFVLGGCR</LinearSequence>
                                            <StartingPosition>130</StartingPosition>
                                            <EndingPosition>138</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12936.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ADR X p1548-1556</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KVFVLGGCR</LinearSequence>
                                            <StartingPosition>130</StartingPosition>
                                            <EndingPosition>138</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12936.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>ADR X p1548-1556</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KVFVLGGCR</LinearSequence>
                                        <StartingPosition>130</StartingPosition>
                                        <EndingPosition>138</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12936.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTLs from mice immunized with HBV X peptide p1548-1556 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 0 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005941</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6.5</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ADR Pol p601-609</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RLADEGLNR</LinearSequence>
                        <StartingPosition>27</StartingPosition>
                        <EndingPosition>35</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P12933.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>54459</EpitopeId>
                <ReferenceStartingPosition>601</ReferenceStartingPosition>
                <ReferenceEndingPosition>609</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005943</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>RLADEGLNR</LinearSequence>
                                            <StartingPosition>27</StartingPosition>
                                            <EndingPosition>35</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ADR Pol p601-609</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>RLADEGLNR</LinearSequence>
                                            <StartingPosition>27</StartingPosition>
                                            <EndingPosition>35</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P12933.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>ADR Pol p601-609</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RLADEGLNR</LinearSequence>
                                        <StartingPosition>27</StartingPosition>
                                        <EndingPosition>35</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P12933.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTLs from mice immunized with HBV ADR pol peptide p601-609 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 0 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005944</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>245.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PAP p274-282</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ATQIPSYKK</LinearSequence>
                        <StartingPosition>274</StartingPosition>
                        <EndingPosition>282</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P15309.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>5118</EpitopeId>
                <ReferenceStartingPosition>274</ReferenceStartingPosition>
                <ReferenceEndingPosition>282</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005946</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ATQIPSYKK</LinearSequence>
                                            <StartingPosition>274</StartingPosition>
                                            <EndingPosition>282</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P15309.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>PAP p274-282</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ATQIPSYKK</LinearSequence>
                                            <StartingPosition>274</StartingPosition>
                                            <EndingPosition>282</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P15309.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>PAP p274-282</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ATQIPSYKK</LinearSequence>
                                        <StartingPosition>274</StartingPosition>
                                        <EndingPosition>282</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P15309.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with human PAP peptide p274-282 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 6 of the 6 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table III</LocationOfData>
                        <TCellId>1005958</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>T cell CD8+</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ATQIPSYKK</LinearSequence>
                                            <StartingPosition>274</StartingPosition>
                                            <EndingPosition>282</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P15309.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Enriched CD8+ T cells were cultured for 7 days and then re-stimulated every 3 days thereafter with peptide-pulsed irradiated autologous APCs (PBMCs cultured with S. Aureus, plus rIL-4 prior to introduction of peptide).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>PAP p274-282</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ATQIPSYKK</LinearSequence>
                                        <StartingPosition>274</StartingPosition>
                                        <EndingPosition>282</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P15309.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>To examine the extent of the overlap of CTL repertoire in A11/Kb transgenic mice relative to human expressing the HLA-A11 antigen, peptides previously tested in A11/Kb mice were evaluated for their ability to induce primary CTL response in human PBMCs in vitro.  The human PAP peptide p274-282 was capable of inducing specific lysis of EBV-transformed lymphoblastoid targets expressing A11 in 2 of 2 tested individuals.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005945</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>128.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>X p69-77</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>CALPFTSAR</LinearSequence>
                        <StartingPosition>69</StartingPosition>
                        <EndingPosition>77</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA62811.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>6003</EpitopeId>
                <ReferenceStartingPosition>69</ReferenceStartingPosition>
                <ReferenceEndingPosition>77</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>1005947</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000581</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CALPFTSAR</LinearSequence>
                                            <StartingPosition>69</StartingPosition>
                                            <EndingPosition>77</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA62811.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>X p69-77</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CALPFTSAR</LinearSequence>
                                            <StartingPosition>69</StartingPosition>
                                            <EndingPosition>77</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA62811.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10407</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A11/Kb mice were immunized by injection of 50ug of HLA-A11 binding-peptide mixed with 140ug of helper IAb-restircted epitope p128-140 of hepatitis B core antigen in PBS/10% DMSO emulsified in incomplete Freund's adjuvant.  At day 11 post-immunization, splenocytes were isolated.  At day 11 post-immunization, splenocytes were isolated and stimulated with 1ug/ml of peptide in the presence or absence of syngeneic irradiated LPS blasts for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>213</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>X p69-77</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CALPFTSAR</LinearSequence>
                                        <StartingPosition>69</StartingPosition>
                                        <EndingPosition>77</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA62811.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10407</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>9</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>7</NumberOfSubjectsResponded>
                            <ResponseFrequency>77.8</ResponseFrequency>
                            <AssayComments>CTLs from mice immunized with HBV X peptide p69-77 were tested for their ability to recognize and lyse peptide-pulsed targets. CTLs from 7of the 9 immunized mice were capable of peptide-specific lysis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table II</LocationOfData>
                        <MhcBindingId>1005948</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>316.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>213</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

